140464-70-6

Basic information

• Product Name: 1,3-Dioxolane, 2-(3,5-dimethoxyphenyl)-
• CAS NO: 140464-70-6
• Molecular Formula: C11H14O4
• Molecular Weight: 210.23
• Mol File: 140464-70-6.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 1,3-Dioxolane, 2-(3,5-dimethoxyphenyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: 1,3-Dioxolane, 2-(3,5-dimethoxyphenyl)-(140464-70-6)
• EPA Substance Registry System: 1,3-Dioxolane, 2-(3,5-dimethoxyphenyl)-(140464-70-6)

Safety Data

• Hazardous Substances Data: 140464-70-6(Hazardous Substances Data)

Upstream product

• 59276-37-8 3,4,5-trimethoxybenzaldehyde dimethyl acetal 
• 98-88-4 benzoyl chloride 
• 7311-34-4 3,5-dimethoxybenzaldehdye 
• 107-21-1 ethylene glycol 
• 101403-71-8 3,4,5-Trimethoxybenzaldehyde diethyl acetal 
• 93-61-8 N-methyl-N-phenylformamide 
• 79-22-1 methyl chloroformate 
• 630-19-3 pivalaldehyde 
• 82073-55-0 3,4,5-Trimethoxybenzaldehyde ethylene acetal 
• 75-77-4 chloro-trimethyl-silane 
• 109-65-9 1-bromo-butane 

Downstream Products

• 894077-48-6 3-[1,3]dioxolan-2-yl-5-methoxyphenol 
• 7311-34-4 3,5-dimethoxybenzaldehdye 

Relevant articles and documents

Asymmetric synthesis of a fully protected ent-actinoidinic acid

(equation presented) The asymmetric synthesis of a fully protected ent-actinoidinic acid derivative 14 is described. As key steps, an enantioselective deprotonation of an arenetricarbonylchromium(0) complex and a diastereoselective Suzuki coupling were ap

3-AMINO-PYRAZOLO[3,4B]PYRIDINES USED AS INHIBITORS OF PROTEIN TYROSINE KINASES FOR TREATING ANGIOGENIC, HYPERPROLIFERATIVE OR NEURODEGENERATIVE DISEASES

The invention relates to compounds of general formula (I), in which R1 and R2 are described in the application, to the use of the compounds of general formula (I) as inhibitors of protein tyrosine kinases for treating various diseases, and to the compounds of general formulas (II) and (III) as intermediate compounds for producing compounds of general formula (I), in which X, R1a and R2a have the meanings as described in general formulas (II) and (III).